CCL19 and neoplasm: In cancer, CCR2 has been implicated in the recruitment of tumor-associated macrophages and MDSCs, which can promote tumor growth and immune evasion.[56,57] CCR7, as mentioned earlier, is the primary receptor for CCL19 and is expressed in various immune cells, including T cells, B cells, and DCs.